Samsung Bioepis’s autoimmune disease treatment SB17 (Samsung Bioepis) Samsung Bioepis has officially commenced its full-scale entry into...
Biosimilar
Celltrion reports robust first-quarter earnings. Celltrion Achieves Record-Breaking First Quarter with Surging Biosimilar Sales Celltrion announced impressive...
Celltrion’s blood cancer medicine Truxima (Celltrion) Celltrion’s Truxima, a leading **blood cancer treatment**, has achieved a significant...
The launch event for Celltrion’s autoimmune disease treatment Omlyclo in Brazil (Celltrion) Celltrion announced Tuesday the official...
(Celltrion) Celltrion announced Friday that it has received product approval from the Japanese Ministry of Health, Labor...
Celltrion Celltrion announced on Friday that it will immediately implement the newly eased US biosimilar development rules...